South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Tensions Trumps Mixed Signals on Iran Deal Keep Oil Markets on Edge as Summer Stockpile Risks Mount Money Market Account Rates on May 24 2026 Top Account Offers 401 APY Amid Declining Yields Nvidia Earnings Report and Commentary Potential Impact of China Chip Restrictions and Trade Policy After Xi Summit Microsofts New Trusted Tech Lead Faces Tension Between Speed and Responsibility in AI Development 401k Millionaire Numbers Dip as Workers Achieve Record Savings Rates Fidelity Q1 Data DocGo Q1 2026 Earnings EPS Misses Estimates but Shares Rise SKE Q1 2026 Earnings Significant EPS Miss Amid Exploration Stage Operations MUR Q1 2026 Earnings Earnings Per Share Surpass Expectations Amid Volatile Oil Markets Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development Kirby KEX Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline Eagle Point Income Company Inc EICC Q4 2025 Earnings Modest EPS Miss Stock Edges Higher ADTRAN Holdings Inc ADTN Edges Higher as Shares Approach Key Resistance Level Enliven Therapeutics ELVN Faces Pressure as Shares Dip 168 Key Support Levels in Focus ZOOZ Strategy Ltd ZOOZ Surges 858 as It Nears Key Resistance Level Danaos Corporation DAC Holds Steady Near Support as Shipping Sector Faces Headwinds Trane Technologies Edges Higher as Steady Demand Supports the Stock TT Qnity Electronics Inc Q Rallies 294 as Shares Approach Key Resistance at 16962 HWH International Inc HWH Edges Lower Amid Consolidation Key Support and Resistance Levels in Focus United Homes Group UHG Holds Steady at 122 as Consolidation Continues Near Key Levels POMDOCTOR LIMITED POM Slips Over 10 as Stock Tests AllTime Support at 010 Quanterix QTRX Rallies 189 as Shares Test Key Resistance Near 282 Indigo Acquisition Corp INAC Holds Steady Near Support as Price Posts Modest Gain Private Payrolls Rise 109000 in April Surpassing Expectations ADP Report Shows Perspective Therapeutics Inc CATX Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress Radiopharm Theranostics RADX Gains Ground Testing Key Resistance at 485